December 2009

Too often, society prods regulators into adopting new drugs and technologies without adequate scientific analysis

Pierantonio Russo, MD ; Alan Adler, MD, MS

Pay for performance is not enough. Fundamental changes in the fundamental relationship have to be taken into account.
A broad consortium of players joins with the NCQA to shine a light on the drugstore

Tom Reinke

Departments

LEGISLATION & REGULATION
Skeptics wonder if sticking sick people with high out-of-pocket costs simply encourages them to avoid care
John Carroll
MEDICATION MANAGEMENT
The Centers for Medicare and Medicaid Services will make the Part D reporting process more difficult and complex
Martin Sipkoff
PLAN WATCH
When your domestic business is steady or even declining, what’s a giant health care company to do but look abroad?
Frank Diamond
TOMORROW’S MEDICINE
Xiaflex may offer a better overall outcome and a much less invasive option than surgery for patients with Dupuytren’s disease
Thomas Morrow, MD